Trial Profile
Large Scale Safety Study of IMOVAX Polio in Selected Cities in China, an Observational Post Marketing Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 May 2016
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions
- Sponsors Sanofi
- 02 Aug 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 Planned end date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.